Turkish Thoracic Journal

Scope & Guideline

Fostering collaboration in the pursuit of respiratory excellence.

Introduction

Welcome to the Turkish Thoracic Journal information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Turkish Thoracic Journal, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageTurkish
ISSN-
PublisherAVES
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationTURK THORAC J / Turk. Thorac. J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, Turkiye

Aims and Scopes

The Turkish Thoracic Journal focuses on a broad spectrum of research related to thoracic diseases, with an emphasis on clinical, epidemiological, and therapeutic aspects of respiratory conditions. The journal serves as a platform for advancing knowledge in pulmonary medicine through original research, reviews, case reports, and clinical studies.
  1. Pulmonary Diseases and Disorders:
    The journal extensively covers various pulmonary conditions including Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, and interstitial lung diseases, providing insights into their pathophysiology, diagnosis, and management.
  2. Impact of COVID-19 on Respiratory Health:
    A significant focus has been placed on understanding the implications of COVID-19 on lung health, including studies on pneumonia, pulmonary rehabilitation, and the long-term effects of the virus on respiratory function.
  3. Epidemiological Studies and Public Health:
    The journal publishes research on the epidemiology of respiratory diseases, highlighting risk factors, prevalence, and the impact of environmental factors such as air pollution and tobacco use.
  4. Innovative Therapeutic Approaches:
    Research on novel treatment strategies and therapeutic interventions for respiratory diseases, including the use of biologics, stem cells, and novel drug delivery systems, is a key aspect of the journal.
  5. Clinical Guidelines and Best Practices:
    The journal aims to disseminate clinical guidelines and evidence-based practices for the management of various respiratory conditions, enhancing the quality of care in pulmonary medicine.
The Turkish Thoracic Journal has notably adapted to emerging health concerns, particularly those arising from the COVID-19 pandemic. Recent publications showcase a shift towards innovative research themes that are gaining traction in thoracic medicine.
  1. Post-COVID-19 Pulmonary Health:
    A surge in studies addressing the long-term pulmonary effects of COVID-19, including post-COVID pulmonary rehabilitation and functional evaluations, reflects a growing concern for survivors of the virus.
  2. Environmental and Societal Impacts on Respiratory Health:
    Increasing attention is being directed towards the impact of environmental factors, such as air pollution and climate change, on respiratory diseases, with calls for urgent action highlighted in recent publications.
  3. Telemedicine and Remote Patient Management:
    The rise of telemedicine as a tool for managing respiratory conditions, particularly during the COVID-19 pandemic, indicates a trend towards integrating technology in patient care and follow-up.
  4. Research on New Tobacco Products:
    There is a noticeable increase in studies focusing on the health effects of electronic cigarettes and heated tobacco products, reflecting the evolving landscape of tobacco use and its implications for lung health.
  5. Mental Health and Respiratory Conditions:
    Emerging themes include the psychological impact of respiratory diseases and the pandemic on patients, indicating a growing recognition of the interplay between mental health and respiratory health.

Declining or Waning

While the Turkish Thoracic Journal continues to evolve, certain traditional themes are becoming less prominent in recent publications. This decline may reflect shifting research priorities or emerging health challenges.
  1. Traditional Smoking Cessation Strategies:
    Research focusing on conventional smoking cessation methods appears to be waning, possibly as newer approaches and technologies gain traction in the field of tobacco control.
  2. Occupational Lung Diseases:
    Although still relevant, the frequency of studies specifically addressing occupational lung diseases, such as asbestosis and silicosis, has decreased, potentially overshadowed by the urgent focus on COVID-19 and its respiratory implications.
  3. Historical Case Reports:
    The publication of historical case reports related to pulmonary diseases seems to be declining, as the journal's emphasis shifts towards contemporary studies and clinical trials.
  4. Pediatric Respiratory Conditions:
    Research centered on pediatric lung diseases, while still important, appears to have diminished in frequency, possibly due to a broader focus on adult respiratory conditions in the context of the pandemic.

Similar Journals

RESPIRATORY MEDICINE

Unraveling Complexities of Respiratory Conditions
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Pulmonology

Advancing lung health through groundbreaking research.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Indian Journal of Respiratory Care

Elevating Standards in Pulmonary Medicine
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

RESPIROLOGY

Fostering Excellence in Pulmonary Studies
Publisher: WILEYISSN: 1323-7799Frequency: 12 issues/year

RESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.

CHEST

Empowering healthcare professionals with authoritative research.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Unlocking Vital Research in Circulatory and Respiratory Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

THORAX

Pioneering insights in pulmonary health.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

EUROPEAN RESPIRATORY JOURNAL

Leading Insights for Pulmonary Health
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Jornal Brasileiro de Pneumologia

Championing excellence in pulmonary and respiratory research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Chronic Respiratory Disease

Exploring breakthroughs in respiratory health.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-9723Frequency: 1 issue/year

Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.